Chmielowska E. Liposomal doxorubicin in first line metastatic HER-2-positive breast cancer for prevention the cardiotoxicity. OncoReview [Internet]. 2015Mar.2 [cited 2024Jul.3];5(1(17):11-5. Available from: https://journalsmededu.pl/index.php/OncoReview/article/view/381